International Drug Parity Act
Executive Summary
Senate version of House bill 1885 introduced by Sens. Dorgan (D-N.D.), Wellstone (D-Minn.) and Snowe (R-Maine). The bill (S 1191) would authorize the reimportation of U.S.-manufactured pharmaceutical products by parties other than pharmaceutical companies, such as wholesalers and pharmacists